Drug Trial Radar · NCT01898273
Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma
Last checked: Nov 19, 2026Latest source record: Sep 9, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
7
Actual
Start
Feb 2014
Primary completion
Sep 2015
Study completion Dec 2015
Sponsor
- Lead sponsor
- Cellectar Biosciences, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 12, 2013
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this trial is to determine the optimal dose and imaging time point(s) of I-124-CLR1404 in subjects with newly diagnosed and recurrent glioma to be used in future trials.
Conditions
- Glioblastoma
Interventions
I-124-CLR1404Drug
single-dose, intravenous
Primary outcomes
What the sponsor says the trial is designed to measure.
- Optimal Imaging Parameters - DoseTime frame: 8 days
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
City of Hope
Duarte, California
Moffitt Cancer Center and Research Institute
Tampa, Florida
University of Maryland School of Medicine
Baltimore, Maryland
Cleveland Clinic
Cleveland, Ohio
Ohio State University Medical Center
Columbus, Ohio
Kettering Medical Center
Kettering, Ohio
Hospital of University of Pennsylvania
Philadelphia, Pennsylvania
University of Wisconsin
Madison, Wisconsin
Medical College of Wisconsin
Milwaukee, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.